Research archive

Javier J. Rodriguez

Javier J. Rodriguez, Independent Director at Gilead Sciences, Inc.. Biography, career history and compensation sourced from Gilead Sciences, Inc. SEC filings and official company website.

About

Javier J. Rodriguez is the Chief Executive Officer of DaVita and has served as an independent director of Gilead since 2020.

He brings significant leadership experience in the healthcare industry, including serving as chief executive officer and in various other executive roles of a Fortune 500 public healthcare company, and is recognized for his vision in transforming how kidney care is delivered while lowering costs for the healthcare system.

Roles

Gilead Sciences, Inc.

Independent Director · Current role

2020–present

External Roles

DaVita

Chief Executive Officer

—

Director Compensation

FY 2025

Fees earned or paid in cash

$95,000

Stock awards

$149,932

FormRSUs (1,516 shares granted May 7, 2025, vested immediately)

Option awards

$149,989

All other compensation

$15,000

NoteIncludes charitable gift matching and related programs

Total

$409,921

Also at Gilead Sciences, Inc.

Daniel P. O'Day

Chairman and Chief Executive Officer

Andrew D. Dickinson

Chief Financial Officer

Johanna Mercier

Chief Commercial and Corporate Affairs Officer

Related

Gilead Sciences, Inc.

Gilead Sciences Cell Design Labs 2017

Gilead Sciences Cymabay Therapeutics 2024

See how Top Bucket AI works for your firm

Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.

Dated reference snapshot as of September 10, 2026. This is not a live financial feed. Verify figures against primary filings before relying on them.